(Q82740448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

P Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Sweiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Nimmagadda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

W Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Rondelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

6 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1326-1330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132027%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.293

17 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients underg

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021

Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.293

7 January 2021